| Autor: |
Park SS; Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA., Perez Perez JL; Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA., Perez Gandara B; Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA., Agudelo CW; Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA., Rodriguez Ortega R; Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA., Ahmed H; Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA., Garcia-Arcos I; Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA., McCarthy C; University College Dublin School of Medicine, Education and Research Centre, St. Vincent's University Hospital, D04 T6F4 Dublin, Ireland., Geraghty P; Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA. |
| Abstrakt: |
Chronic obstructive pulmonary disease (COPD) patients frequently suffer from multiple comorbidities, resulting in poor outcomes for these patients. Diabetes is observed at a higher frequency in COPD patients than in the general population. Both type 1 and 2 diabetes mellitus are associated with pulmonary complications, and similar therapeutic strategies are proposed to treat these conditions. Epidemiological studies and disease models have increased our knowledge of these clinical associations. Several recent genome-wide association studies have identified positive genetic correlations between lung function and obesity, possibly due to alterations in genes linked to cell proliferation; embryo, skeletal, and tissue development; and regulation of gene expression. These studies suggest that genetic predisposition, in addition to weight gain, can influence lung function. Cigarette smoke exposure can also influence the differential methylation of CpG sites in genes linked to diabetes and COPD, and smoke-related single nucleotide polymorphisms are associated with resting heart rate and coronary artery disease. Despite the vast literature on clinical disease association, little direct mechanistic evidence is currently available demonstrating that either disease influences the progression of the other, but common pharmacological approaches could slow the progression of these diseases. Here, we review the clinical and scientific literature to discuss whether mechanisms beyond preexisting conditions, lifestyle, and weight gain contribute to the development of COPD associated with diabetes. Specifically, we outline environmental and genetic confounders linked with these diseases. |
